---
title: "Nuwellis Settles Lawsuit With E.F. Hutton, Resolving Dispute"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284059109.md"
description: "Nuwellis, Inc. has settled a lawsuit with E.F. Hutton, agreeing to pay $204,000 without admitting liability. The lawsuit, filed in February 2026, alleged breach of an engagement letter for securities offerings. The settlement includes a mutual release of claims and dismissal of the lawsuit. Currently, Nuwellis stock (NUWE) holds a Hold rating with a price target of $1.31, but faces challenges due to weak financial fundamentals and ongoing losses. The company's market cap is $2.93M, and it operates in the medical technology sector, relying on capital markets for growth."
datetime: "2026-04-24T22:14:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284059109.md)
  - [en](https://longbridge.com/en/news/284059109.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284059109.md)
---

# Nuwellis Settles Lawsuit With E.F. Hutton, Resolving Dispute

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An update from Nuwellis ( (NUWE) ) is now available.

On February 26, 2026, E.F. Hutton & Co. filed a complaint in the New York State Supreme Court alleging that Nuwellis, Inc. breached an engagement letter appointing Hutton as exclusive placement agent for one or more registered securities offerings and seeking compensatory and punitive damages plus related costs. On April 24, 2026, Nuwellis entered into a Settlement Agreement and Release with Hutton, agreeing to pay $204,000 within five days in a deal with no admission of liability, mutual release of all claims, and a commitment by Hutton to dismiss the lawsuit with prejudice, effectively removing a legal overhang for the company and its stakeholders.

The most recent analyst rating on (NUWE) stock is a Hold with a $1.31 price target. To see the full list of analyst forecasts on Nuwellis stock, see the NUWE Stock Forecast page.

**Spark’s Take on NUWE Stock**

According to Spark, TipRanks’ AI Analyst, NUWE is a Neutral.

The score is primarily constrained by weak financial fundamentals—large ongoing losses and negative free cash flow with limited cash on hand—alongside bearish technicals showing a sustained downtrend. Earnings-call progress on margins and operational focus, plus financing and M&A activity, provide some support but do not yet offset the near-term funding and execution risks.

To see Spark’s full report on NUWE stock, click here.

**More about Nuwellis**

Nuwellis, Inc. operates in the medical technology sector, though this announcement does not detail its specific products or services. The company engages financial intermediaries such as E.F. Hutton & Co. as placement agents for its registered securities offerings, highlighting its reliance on capital markets to support its business activities and growth plans.

**Average Trading Volume:** 2,090,066

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $2.93M

Learn more about NUWE stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)

## Related News & Research

- [Nuwellis Q1 revenue rises 26% on core category growth](https://longbridge.com/en/news/286096144.md)
- [Nuwellis Q4 revenue rises on US console growth](https://longbridge.com/en/news/278555004.md)
- [How Investors May Respond To American Healthcare REIT (AHR) Cutting 2026 Profit Outlook After Q1 Results](https://longbridge.com/en/news/286866277.md)
- [Twin Capital Management Inc. Grows Stock Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/287213128.md)
- [03:00 ETGreenberg Traurig's Capital Markets Practice Recognized Across Five Winning Deals of the Year at Islamic Finance News Awards 2025](https://longbridge.com/en/news/287020144.md)